{"transactions":[{"id":2033264,"issuer":{"id":4567,"kind":"organization","name":"COMPASS Pathways plc"},"owners":[{"id":117322,"kind":"person","name":"FALVEY MICHAEL","position":1,"cik":"0001286197","reported_name":"FALVEY MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Share Option (Right to Buy)","published_at":"2023-02-03T21:25:09.000Z","date":"2023-02-02","kind":"grant","acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The share option shall vest in forty-eight equal monthly installments beginning on March 2, 2023."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":45000,"derivative":{"exercise_price":10.85,"exercise_date":"2023-03-02","expiration_date":"2033-02-01","underlying":"Ordinary Shares","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0001816590-23-000016","document":"wf-form4_167545948442433.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1816590/000181659023000016/wf-form4_167545948442433.xml","form_type":"4"}},{"id":2033263,"issuer":{"id":4567,"kind":"organization","name":"COMPASS Pathways plc"},"owners":[{"id":117322,"kind":"person","name":"FALVEY MICHAEL","position":1,"cik":"0001286197","reported_name":"FALVEY MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Ordinary Shares","published_at":"2023-02-03T21:25:09.000Z","date":"2023-02-02","kind":"grant","acquired":true,"shares":22500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents an award of Restricted Share Units (\"RSUs\") granted under the Issuer's 2020 Share Option and Incentive Plan. Each RSU represents a contingent right to receive one Ordinary Share. The RSUs vest in four equal annual installments, with the first installment vesting on February 2, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents an award of Restricted Share Units (\"RSUs\") granted under the Issuer's 2020 Share Option and Incentive Plan. Each RSU represents a contingent right to receive one Ordinary Share. The RSUs vest in four equal annual installments, with the first installment vesting on February 2, 2024."}],"balance_after":22500,"source":{"system":"sec-edgar","filing":"0001816590-23-000016","document":"wf-form4_167545948442433.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816590/000181659023000016/wf-form4_167545948442433.xml","form_type":"4"}},{"id":4089628,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":117322,"kind":"person","name":"FALVEY MICHAEL","position":1,"cik":"0001286197","reported_name":"FALVEY MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO & Treasurer"}}],"security":"Stock Option (right to buy)","published_at":"2018-01-25T16:30:49.000Z","date":"2018-01-24","kind":"grant","acquired":true,"shares":95000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on January 24, 2018.  The shares underlying this option vest as to 25% of the shares on January 24, 2019, with the remaining 75% vesting in 36 equal monthly installments thereafter."}],"balance_after":95000,"derivative":{"exercise_price":10.45,"expiration_date":"2028-01-23","underlying":"Common Stock","underlying_shares":95000},"source":{"system":"sec-edgar","filing":"0001209191-18-005381","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1286197/000120919118005381/doc4.xml","form_type":"4"}},{"id":4210261,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":117322,"kind":"person","name":"FALVEY MICHAEL","position":1,"cik":"0001286197","reported_name":"FALVEY MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO & Treasurer"}}],"security":"Nonstatutory Stock Option (right to buy)","published_at":"2017-09-13T16:09:06.000Z","date":"2017-09-11","kind":"grant","acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on September 11, 2017.  The shares underlying this option vest as to 25% of the shares on September 11, 2018, with the remaining 75% vesting in 36 equal monthly installments thereafter."}],"balance_after":125000,"derivative":{"exercise_price":10.6,"expiration_date":"2027-09-10","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001209191-17-052585","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1286197/000120919117052585/doc4.xml","form_type":"4"}}]}